公开(公告)号：US20230346873A1

公开(公告)日：2023-11-02

申请号：US18350891

申请日：2023-07-12

申请人： DailyColors Health Inc.

发明人： Hartley Pond

IPC分类号： A61K36/9068 ,  A23L33/105 ,  A23L33/00 ,  A61K9/00 ,  A61K9/14 ,  A61K45/06 ,  A61K36/23 ,  A61K36/45 ,  A61K36/752 ,  A61K36/81 ,  A61K36/21

CPC分类号： A61K36/9068 ,  A23L33/105 ,  A23L33/30 ,  A61K9/0053 ,  A61K9/14 ,  A61K45/06 ,  A61K36/23 ,  A61K36/45 ,  A61K36/752 ,  A61K36/81 ,  A61K36/21

摘要： Compositions and methods are presented in which specific compounds or extracts having known or suspected activity are combined with a plurality of chemically distinct polyphenols to achieve significantly improved biological activity. In general, it is contemplated that the enhanced activity is due to the pleiotropic effects of the compounds or extracts together with the distinct polyphenols where these compounds act synergistically on one, and more typically more than one metabolic and/or signaling pathway.

公开(公告)号：US20230321248A1

公开(公告)日：2023-10-12

申请号：US18201375

申请日：2023-05-24

申请人： GENAXA INC.

发明人： Max Spielberg ,  David Johnson

IPC分类号： A61K35/644 ,  A61K36/736 ,  A61K36/235 ,  A61K47/26 ,  A61K31/167 ,  A61K47/46 ,  A61K36/35 ,  A61K47/12 ,  A61K9/00 ,  A61K36/88 ,  A61K36/9068 ,  A61K36/9066 ,  A61P11/14 ,  A61K36/074

CPC分类号： A61K47/46 ,  A61K9/0053 ,  A61K9/0095 ,  A61K31/167 ,  A61K35/644 ,  A61K36/074 ,  A61K36/235 ,  A61K36/35 ,  A61K36/736 ,  A61K36/88 ,  A61K36/9066 ,  A61K36/9068 ,  A61K47/12 ,  A61K47/26 ,  A61P11/14

摘要： A stable pharmaceutical formulation or suspension has acetaminophen, a suspension agent, and a diluent. The formulation or suspension has viscosity suitable for drinking.

公开(公告)号：US20230233636A1

公开(公告)日：2023-07-27

申请号：US17656554

申请日：2022-03-25

申请人： Qingdao Baishishankang Traditional Chinese Medicine Technology Co., Ltd.

发明人： Ping Lin ,  Zixuan Lin

IPC分类号： A61K36/232 ,  A61K36/185 ,  A61K36/605 ,  A61K36/77 ,  A61K36/076 ,  A61K36/8945 ,  A61K36/8969 ,  A61K36/482 ,  A61K36/23 ,  A61K36/725 ,  A61K36/07 ,  A61K36/9068 ,  A61K36/54 ,  A61K36/752 ,  A61K36/254 ,  A61P25/20

CPC分类号： A61K36/232 ,  A61K36/07 ,  A61K36/23 ,  A61K36/54 ,  A61K36/076 ,  A61K36/77 ,  A61K36/185 ,  A61K36/254 ,  A61K36/482 ,  A61K36/605 ,  A61K36/725 ,  A61K36/752 ,  A61K36/8945 ,  A61K36/8969 ,  A61K36/9068 ,  A61P25/20 ,  A61K2236/15

摘要： The disclosure relates to a traditional Chinese medicine composition and product for improving sleep by balancing yin and yang, a method for making the same and use thereof, and belongs to the technical field of traditional Chinese medicine. The disclosure provides a traditional Chinese medicine composition for improving sleep by balancing yin and yang, which has reasonable compatibility of all herbal medicines, nourishes yin to suppress yang, tonifies blood and promotes blood, regulates qi and soothes the nerves, and has the functions of reconciling yin and yang and balancing qi and blood. The composition may fundamentally improve sleep quality, with an effective rate of 100%. At the same time, all the medicines in the prescription are raw materials of medicine food homology, which are safe and effective, not cause side effects and mental dependence on the human body, and may be taken for a long time.

公开(公告)号：US20230226082A1

公开(公告)日：2023-07-20

申请号：US17985097

申请日：2022-11-10

申请人： Bioved Pharmaceuticals, Inc.

发明人： Deepa Chitre ,  Debendranath Dey ,  Satej R Nadkarni

IPC分类号： A61K31/585 ,  A61K31/19 ,  A61K31/12 ,  A61K36/9068 ,  A61K36/9066 ,  A61K36/324 ,  A61K36/81 ,  A61K31/675 ,  A61K31/4025 ,  A61K31/375 ,  A61K33/30 ,  A61K31/198 ,  A61K9/20 ,  A61K9/16 ,  A61P31/14 ,  A61P27/00

CPC分类号： A61K31/585 ,  A61K31/19 ,  A61K31/12 ,  A61K36/9068 ,  A61K36/9066 ,  A61K36/324 ,  A61K36/81 ,  A61K31/675 ,  A61K31/4025 ,  A61K31/375 ,  A61K33/30 ,  A61K31/198 ,  A61K9/2059 ,  A61K9/2009 ,  A61K9/2027 ,  A61K9/1611 ,  A61K9/1652 ,  A61P31/14 ,  A61P27/00 ,  A61K2236/333 ,  A61K2236/53

摘要： Methods and formulations for treating and preventing LONG COVID sequelae are provided. An example method treats loss of smell and taste from SARS-CoV-2 infection, including assessing the patient, administering a composition with dosage between 1750-3600 mg per day, wherein the composition comprises a mixture of at least a withanolide-A, a boswellic acid, a [6]-gingerol, and a curcuminoid. Another example method treats memory loss or brain fog from SARS-CoV-2 infection, including assessing the patient, and administering a regenerative and neuroprotective composition comprising a mixture of withanoside VI, withanolide A, a Boswellia serrata plant, a Zingiber officinale rhizome, and a Curcuma longa rhizome. The compositions were found effective, achieving statistical significance in a multi-center, randomized, double-blind, placebo-controlled phase III clinical trial.

公开(公告)号：US20230201347A1

公开(公告)日：2023-06-29

申请号：US18111702

申请日：2023-02-20

申请人： Next2Me, LLC

发明人： Ralph L. Peterson ,  Renee D. Williman

IPC分类号： A61K41/00 ,  A61K31/714 ,  A61K31/4415 ,  A61K36/68 ,  A61K36/23 ,  A61K36/06 ,  A61K36/9068 ,  A61K31/51 ,  A61K31/525 ,  A61K31/455 ,  A61K31/197 ,  A61K31/661 ,  A61K31/519 ,  A61K31/4188

CPC分类号： A61K41/0004 ,  A61K31/51 ,  A61K31/197 ,  A61K31/455 ,  A61K31/519 ,  A61K31/525 ,  A61K31/661 ,  A61K31/714 ,  A61K31/4188 ,  A61K31/4415 ,  A61K36/06 ,  A61K36/23 ,  A61K36/68 ,  A61K36/9068

摘要： Biochemical scaffolds for regulating mammalian cell function. The biochemical scaffolds include a base liquid medium, a bioenergetic platform and a vibrational platform. The bioenergetic platform includes at least one Krebs cycle modulator and/or neurotransmitter modulator. The vibrational platform includes at least one energy signature component, e.g., an herb. The biochemical scaffold is subjected to harmonic oscillation for a defined, predetermined period of time, wherein the energy signature of the energy signature component is imparted to, captured, replicated, and retained by the liquid medium, and, when the biochemical scaffolds are delivered to and, thus, in communication with biological tissue, the biochemical scaffolds induce specific biochemical activities via the resonant transfer of the retained energy signature to the biological tissue and, hence, endogenous cells thereof.

公开(公告)号：US20230190847A1

公开(公告)日：2023-06-22

申请号：US17999267

申请日：2021-05-20

申请人： ID4FEED

发明人： Camille ROZIER ,  Francois GAUTIER

IPC分类号： A61K36/282 ,  A23L33/105 ,  A23L33/115 ,  A23K10/30 ,  A23K20/158 ,  A61K47/44 ,  A61K36/28 ,  A61K36/8962 ,  A61K36/54 ,  A61K36/53 ,  A61K36/81 ,  A61K36/288 ,  A61K36/82 ,  A61K36/87 ,  A61K36/9068

CPC分类号： A61K36/282 ,  A23L33/105 ,  A23L33/115 ,  A23K10/30 ,  A23K20/158 ,  A61K47/44 ,  A61K36/28 ,  A61K36/8962 ,  A61K36/54 ,  A61K36/53 ,  A61K36/81 ,  A61K36/288 ,  A61K36/82 ,  A61K36/87 ,  A61K36/9068 ,  A61K2236/33 ,  A61K2236/51 ,  A61K2236/15 ,  A61K2236/37

摘要： A process for preparing a total extract which is a mixture of a fresh plant matter with a fatty matter includes a. contacting the fresh plant matter which comprises at least 10% of water by weight relative to its total weight before or after desiccation loss, with the fatty matter chosen from hydrogenated oil or fat at a temperature between 50° C. and 180° C.; b. grinding the plant matter-fatty matter mixture at said temperature between 50° C. to 180° C.; and c. recovering a total extract that is solid or liquid at ambient temperature with a concentration of less than or equal to 4% of water by weight relative to the total weight of the total extract. Extracts recovered from such process and treatments using the extracts are also disclosed.

公开(公告)号：US20230149452A1

公开(公告)日：2023-05-18

申请号：US17917294

申请日：2021-04-06

申请人： Yogesh BENDALE ,  Vineeta BENDALE

发明人： Yogesh BENDALE ,  Vineeta BENDALE

IPC分类号： A61K33/36 ,  A61K9/00 ,  A61K9/51 ,  A61K36/9068 ,  A61K36/42 ,  A61K36/88

CPC分类号： A61K33/36 ,  A61K9/0053 ,  A61K9/5176 ,  A61K36/9068 ,  A61K36/42 ,  A61K36/88 ,  A61K2236/37 ,  A61K2236/333 ,  A61K2236/51

摘要： The present invention is drawn to a surface functionalized nanoparticle of Tetra-arsenic Hexoxide by carbon- and carbonbased compounds, that are largely mono-dispersed and bi-pyramidal faceted, having presence of silicon, floats on water, storage stable, capable of oral administration for its effect against multiple chronic diseases including cancer.

公开(公告)号：US20230148646A1

公开(公告)日：2023-05-18

申请号：US17919658

申请日：2021-04-13

申请人： Patrick Todorov ANGELOV ,  Kamen Stoychev STOYCHEV ,  Nevan John MCLEAY ,  Ivo Petrov SPASOV

发明人： Kamen Stoychev STOYCHEV ,  Nevan John MCLEAY ,  Petrov Petrov SPASOV ,  Patrick Todorov ANGELOV

IPC分类号： A23L33/165 ,  A23L29/231 ,  A23L33/105 ,  A23L33/15 ,  A61K36/9068

CPC分类号： A23L33/165 ,  A23L29/231 ,  A23L33/105 ,  A23L33/15 ,  A61K36/9068 ,  A23V2002/00

摘要： The food additive includes the following components in weight percent: liquorice—Glycyrrhiza glabra from 1.19% to 47.61%, sweet wormwood—Artemisia annua from 1.19% to 47.61%, quinine bark extract—Cinho from 1.19% to 47.61%, hawthorn extract—Crataegus from 1.19% to 47.61%, dandelion extract—Taraxcum from 1.19% to 47.61%, vitamin C—Ascorbic acid from 1.19% up to 47.61%, DD-Galacturonic acid from 1.19% to 47.61%, apple pectin from 1.19% to 47.61%, bitter orange—Citrus aurantium from 1.19% to 47.61%, ginger—Zingiber officinale from 0.23% to 11.9%, Radix isatidis from 0.23% to 11.9%, Lindera aggregate—0.23% to 11.9%, woad—Isatis indigotica from 0.23% to 9.52%, Torreya nucifera from 0.23% to 9.52%, geranium extract—Pelargonium from 0.23% to 9.52%, Zinc from 0.23% to 2.38% and Sodium Selenite from 0.00119% to 0.04762%.

公开(公告)号：US20230121249A1

公开(公告)日：2023-04-20

申请号：US17802380

申请日：2021-01-20

申请人： Suzhou Regen-Pharma Tech Co., Ltd.

发明人： Be XIE ,  Xuefeng REN

IPC分类号： A61K36/9068 ,  A61K36/233 ,  A61K36/752 ,  A61K36/69 ,  A61K36/54 ,  A61K36/65 ,  A61K35/62 ,  A61K36/484 ,  A61K36/344 ,  A61K36/284 ,  A61K36/8888 ,  A61K35/618 ,  A61K36/062 ,  A61K36/899 ,  A61P3/06 ,  A61P9/10

摘要： A traditional Chinese medicine composition, and preparation method, and application thereof. The traditional Chinese medicine composition includes the following raw medicines in parts by weight: 10-35 parts of root of Chinese thorowax, 5-25 parts of immature bitter orange, 3-20 parts of fresh root and rhizome of sorrel rhubarb, 3-20 parts of root of baikal skullcap, 3-20 parts of white peony root, 3-15 parts of dried ginger, 5-20 parts of leech, 3-20 parts of root of ural licorice, 3-20 parts of root pilose asiabell, 3-20 parts of rhizome of largehead atractylodes, and 3-25 parts of tuber of pinellia. The traditional Chinese medicine composition has excellent effects in lowering blood lipids and cholesterol levels, particularly in lowering blood triglyceride. The traditional Chinese medicine composition also has excellent effects in slowing formation of atherosclerotic plaques, clearing the atherosclerotic plaques, and preventing and treating atherosclerosis.

公开(公告)号：US11622949B1

公开(公告)日：2023-04-11

申请号：US17881095

申请日：2022-08-04

申请人： Gad M. Gilad ,  Varda H. Gilad

发明人： Gad M. Gilad ,  Varda H. Gilad

IPC分类号： A61P19/02 ,  A61K31/155 ,  A61K31/167 ,  A61K31/726 ,  A61K31/7008 ,  A61K31/10 ,  A61K31/728 ,  A61K38/39 ,  A61K31/121 ,  A61K31/7076 ,  A61K36/48 ,  A61K36/54 ,  A61K36/324 ,  A61K36/9068 ,  A61K31/455

摘要： Dietary supplements, nutraceutical compositions, medical foods, animal feeds, and pharmaceutical compositions for treating osteoarthritis and other osteo-articular conditions involving neuropathy and associated symptoms. A synergistic composition containing a high dose range of agmatine and acceptable salts thereof and in combination with other active ingredients having salutary effects in treating osteoarthritis and other osteo-articular conditions involving neuropathy and associated symptoms. The composition prepared with excipients and compatible carriers, including but not limited to, powders, tablets, capsules, controlled release carriers, lozenges and chewable preparations, liquid suspensions, suspensions in an edible supporting matrix or foodstuff and oral rehydration solution to facilitate consumption.